Thank you for showing an interest in Novo Nordisk. Until our new subscription site is ready, please send us an email indicating whether you wish to subscribe to:

  • press releases (press material is intended for media only)
  • announcements on material news 
  • announcements on trading of shares
  • or all the above

We will save your email address and choice of subscription only. Learn more in our Notice of Personal Data Processing.


If you don't wish to receive our news anymore, please send us an email indicating that you wish to unsubscribe.